Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
More rigorous clinical trials are required to assess efficacy, safety, and tolerability
Summary: Retatrutide and 5-Amino-1MQ are both unlicensed compounds in the UK retatrutide is an investigational triple incretin receptor agonist in clinical trials, whilst 5-Amino-1MQ is a research chemical with no approved human therapeutic use
Esposito L
If applicable, LifeMD works with health insurance providers to help patients manage costs for patient care
Marketing Practices Excellent No urgency, with an unusual upfront FDA disclaimer
Are there fees associated with cancellations and returns
US$ 26.48
US$ 24.26
US$ 20.09
